Sotac Pharmaceuticals Ltd.

•

₹ 90.050%

2026-08-21

sotacpharma.comBSE: -NSE: SOTAC

Market Cap₹ 97 Cr.

Current Price₹ 90

High / Low₹ 140 / 86

Stock P/E16.7

Book Value₹ 50

Price to Book2.46

Dividend Yield0.23 %

ROCE16.4 %

ROE18.8 %

Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2022 • Tablet: 78.7% • Capsules: 10.6% • Liquid: 7.1% • Ointment: 3.7%

PROS

Company has delivered good sales growth of 27.7% CAGR over last 5 years
Operating margins have improved to 14.1% from 8.7%
Institutional investors have been accumulating - FII+DII up 7.8pp
Attractively priced for its growth - PEG of 0.4

CONS

Operating cash flow has been negative in recent years
Receivables are growing faster than sales - a possible quality concern
A large part of profit comes from other income (35.0% of PBT)
Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.81x)
Equity base is being diluted - shares outstanding up 380.4%
Total debt has risen sharply - up 75.8% year on year

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name	CMP Rs.	P/E	Mar Cap Rs.Cr.	Div Yld %	NP Qtr Rs.Cr.	Qtr Profit Var %	Sales Qtr Rs.Cr.	Qtr Sales Var %	ROCE %	OPM %
1.	SUNPHARMA	1898.00	37.65	455393.78	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	8525.00	77.37	226311.96	0.35	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	5013.00	87.43	190678.41	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	CIPLA	1416.00	33.94	114392.01	0.92	785.55	-39.18	7119.28	4.13	16.00	16.73
5.	ZYDUSLIFE	1105.00	24.42	110224.17	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
6.	LUPIN	2220.00	18.36	101506.15	0.81	1416.98	16.01	8276.89	34.28	28.86	29.59
7.	MANKIND	2391.00	48.34	98747.34	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
8.	DRREDDY	1171.00	30.33	97740.54	0.68	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	LAURUSLABS	1807.00	89.30	97634.42	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
10.	AUROPHARMA	1615.15	25.03	92932.16	0.25	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	BIOCON	414.30	136.32	67518.23	0.12	136.80	53.36	4336.00	10.89	3.26	19.54
12.	SOTAC	87.40	16.75	96.58	0.23	1.35	—	25.25	27.08	16.40	8.79

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2022	Dec 2022	Jun 2023	Dec 2023	Jun 2024
	20	20	25	26	25
	18	18	23	23	23
Operating Profit	—	—	—	—	—
OPM %	—	—	—	—	—
Other Income	0	0	0	1	0
Interest	0	0	0	1	0
Depreciation	0	1	1	1	1
	1	1	2	1	1
Tax %	54.95%	39.37%	34.67%	40.82%	-3.85%
Net Profit	0	0	0	1	1
	2	0	1	1	1
Equity Capital	2	8	11	11	11
Reserves	0	0	0	0	0
Promoter Pledge %	0.00%	0.00%	0.00%	0.00%	0.00%
Equity Capital	2	8	11	11	11
Reserves	0	0	0	0	0
Promoter Pledge %	0.00%	0.00%	0.00%	0.00%	0.00%

Jun 2022

: 20
: 18
Operating Profit: —
OPM %: —
Other Income: 0
Interest: 0
Depreciation: 0
: 1
Tax %: 54.95%
Net Profit: 0
: 2
Equity Capital: 2
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 2
Reserves: 0
Promoter Pledge %: 0.00%

Dec 2022

: 20
: 18
Operating Profit: —
OPM %: —
Other Income: 0
Interest: 0
Depreciation: 1
: 1
Tax %: 39.37%
Net Profit: 0
: 0
Equity Capital: 8
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 8
Reserves: 0
Promoter Pledge %: 0.00%

Jun 2023

: 25
: 23
Operating Profit: —
OPM %: —
Other Income: 0
Interest: 0
Depreciation: 1
: 2
Tax %: 34.67%
Net Profit: 0
: 1
Equity Capital: 11
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 11
Reserves: 0
Promoter Pledge %: 0.00%

Dec 2023

: 26
: 23
Operating Profit: —
OPM %: —
Other Income: 1
Interest: 1
Depreciation: 1
: 1
Tax %: 40.82%
Net Profit: 1
: 1
Equity Capital: 11
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 11
Reserves: 0
Promoter Pledge %: 0.00%

Jun 2024

: 25
: 23
Operating Profit: —
OPM %: —
Other Income: 0
Interest: 0
Depreciation: 1
: 1
Tax %: -3.85%
Net Profit: 1
: 1
Equity Capital: 11
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 11
Reserves: 0
Promoter Pledge %: 0.00%

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	29	49	73	77	104	97	96
	27	47	67	70	96	83	86
Operating Profit	2	2	6	8	9	18	—
OPM %	7	3	9	10	8	18	—
Other Income	0	0	0	0	0	4	1
Interest	0	1	1	2	2	3	2
Depreciation	1	3	1	2	3	4	3
	0	-2	5	4	4	11	5
Tax %	75	-15	39	42	10	17	28
Net Profit	0	-2	3	2	4	9	4
EPS	1	-10	13	4	4	7	—
Dividend Payout %	0	0	16	0	0	1	—
Minority Interest	0	0	0	1	1	-1	0
Share of Associates	0	0	0	0	0	0	0
Adjusted EPS	0	-3	4	4	4	7	—
Minority Interest	0	0	0	1	1	-1	0
Share of Associates	0	0	0	0	0	0	0
Adjusted EPS	0	-3	4	4	4	7	—

Mar 2020

: 29
: 27
Operating Profit: 2
OPM %: 7
Other Income: 0
Interest: 0
Depreciation: 1
: 0
Tax %: 75
Net Profit: 0
EPS: 1
Dividend Payout %: 0
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 0
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 0

Mar 2021

: 49
: 47
Operating Profit: 2
OPM %: 3
Other Income: 0
Interest: 1
Depreciation: 3
: -2
Tax %: -15
Net Profit: -2
EPS: -10
Dividend Payout %: 0
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: -3
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: -3

Mar 2022

: 73
: 67
Operating Profit: 6
OPM %: 9
Other Income: 0
Interest: 1
Depreciation: 1
: 5
Tax %: 39
Net Profit: 3
EPS: 13
Dividend Payout %: 16
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 4
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 4

Mar 2023

: 77
: 70
Operating Profit: 8
OPM %: 10
Other Income: 0
Interest: 2
Depreciation: 2
: 4
Tax %: 42
Net Profit: 2
EPS: 4
Dividend Payout %: 0
Minority Interest: 1
Share of Associates: 0
Adjusted EPS: 4
Minority Interest: 1
Share of Associates: 0
Adjusted EPS: 4

Mar 2024

: 104
: 96
Operating Profit: 9
OPM %: 8
Other Income: 0
Interest: 2
Depreciation: 3
: 4
Tax %: 10
Net Profit: 4
EPS: 4
Dividend Payout %: 0
Minority Interest: 1
Share of Associates: 0
Adjusted EPS: 4
Minority Interest: 1
Share of Associates: 0
Adjusted EPS: 4

Mar 2025

: 97
: 83
Operating Profit: 18
OPM %: 18
Other Income: 4
Interest: 3
Depreciation: 4
: 11
Tax %: 17
Net Profit: 9
EPS: 7
Dividend Payout %: 1
Minority Interest: -1
Share of Associates: 0
Adjusted EPS: 7
Minority Interest: -1
Share of Associates: 0
Adjusted EPS: 7

TTM

: 96
: 86
Operating Profit: —
OPM %: —
Other Income: 1
Interest: 2
Depreciation: 3
: 5
Tax %: 28
Net Profit: 4
EPS: —
Dividend Payout %: —
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: —
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: —

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: 28%
3 Years:: 10%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: 147%
3 Years:: 41%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: -11%
1 Year:: -28%

RETURN ON EQUITY

10 Years:: —
5 Years:: 7%
3 Years:: 20%
Last Year:: 19%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
LIABILITIES	-	-	-	-	-	-
Equity Capital	2	2	2	8	11	11
	1	0	4	2	34	42
	7	8	6	14	10	19
Trade Payables	11	13	20	25	29	19
	9	11	2	24	20	32
Total Liabilities	30	35	35	74	104	123
ASSETS	-	-	-	-	-	-
	16	17	9	26	36	49
Capital Work in Progress	0	0	0	0	5	0
	0	0	0	0	2	4
	2	5	5	14	18	20
	0	0	0	0	26	34
Cash & Bank	0	0	0	10	3	2
	11	13	21	24	13	14
Total Assets	30	35	35	74	104	123
Total Debt	13	17	7	22	25	44
Net Working Capital	-6	-5	-2	1	17	18
Contingent Liabilities	0	0	0	0	0	2
Book Value per Share	13.29	10.84	28.79	12.41	40.96	48.19
Face Value	10.00	10.00	10.00	10.00	10.00	10.00
Total Debt	13	17	7	22	25	44
Net Working Capital	-6	-5	-2	1	17	18
Contingent Liabilities	0	0	0	0	0	2
Book Value per Share	13.29	10.84	28.79	12.41	40.96	48.19
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Mar 2020

Equity Capital: 2
: 1
: 7
Trade Payables: 11
: 9
Total Liabilities: 30
: 16
Capital Work in Progress: 0
: 0
: 2
: 0
Cash & Bank: 0
: 11
Total Assets: 30
Total Debt: 13
Net Working Capital: -6
Contingent Liabilities: 0
Book Value per Share: 13.29
Face Value: 10.00
Total Debt: 13
Net Working Capital: -6
Contingent Liabilities: 0
Book Value per Share: 13.29
Face Value: 10.00

Mar 2021

Equity Capital: 2
: 0
: 8
Trade Payables: 13
: 11
Total Liabilities: 35
: 17
Capital Work in Progress: 0
: 0
: 5
: 0
Cash & Bank: 0
: 13
Total Assets: 35
Total Debt: 17
Net Working Capital: -5
Contingent Liabilities: 0
Book Value per Share: 10.84
Face Value: 10.00
Total Debt: 17
Net Working Capital: -5
Contingent Liabilities: 0
Book Value per Share: 10.84
Face Value: 10.00

Mar 2022

Equity Capital: 2
: 4
: 6
Trade Payables: 20
: 2
Total Liabilities: 35
: 9
Capital Work in Progress: 0
: 0
: 5
: 0
Cash & Bank: 0
: 21
Total Assets: 35
Total Debt: 7
Net Working Capital: -2
Contingent Liabilities: 0
Book Value per Share: 28.79
Face Value: 10.00
Total Debt: 7
Net Working Capital: -2
Contingent Liabilities: 0
Book Value per Share: 28.79
Face Value: 10.00

Mar 2023

Equity Capital: 8
: 2
: 14
Trade Payables: 25
: 24
Total Liabilities: 74
: 26
Capital Work in Progress: 0
: 0
: 14
: 0
Cash & Bank: 10
: 24
Total Assets: 74
Total Debt: 22
Net Working Capital: 1
Contingent Liabilities: 0
Book Value per Share: 12.41
Face Value: 10.00
Total Debt: 22
Net Working Capital: 1
Contingent Liabilities: 0
Book Value per Share: 12.41
Face Value: 10.00

Mar 2024

Equity Capital: 11
: 34
: 10
Trade Payables: 29
: 20
Total Liabilities: 104
: 36
Capital Work in Progress: 5
: 2
: 18
: 26
Cash & Bank: 3
: 13
Total Assets: 104
Total Debt: 25
Net Working Capital: 17
Contingent Liabilities: 0
Book Value per Share: 40.96
Face Value: 10.00
Total Debt: 25
Net Working Capital: 17
Contingent Liabilities: 0
Book Value per Share: 40.96
Face Value: 10.00

Mar 2025

Equity Capital: 11
: 42
: 19
Trade Payables: 19
: 32
Total Liabilities: 123
: 49
Capital Work in Progress: 0
: 4
: 20
: 34
Cash & Bank: 2
: 14
Total Assets: 123
Total Debt: 44
Net Working Capital: 18
Contingent Liabilities: 2
Book Value per Share: 48.19
Face Value: 10.00
Total Debt: 44
Net Working Capital: 18
Contingent Liabilities: 2
Book Value per Share: 48.19
Face Value: 10.00

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	0	-0	6	8	-16	-4
Cash from Investing	-12	-3	-4	-12	-20	-14
Cash from Financing	11	3	-3	13	29	16
	-0	-0	0	10	-6	-2
Free Cash Flow	0	-3	6	-11	-34	-16
OCF / Net Profit	0.65	0.13	2.21	3.56	-4.49	-0.47
Cumulative 5-Year FCF	0	0	0	0	0	-59
OCF / Net Profit	0.65	0.13	2.21	3.56	-4.49	-0.47
Cumulative 5-Year FCF	0	0	0	0	0	-59

Mar 2020

: 0
Cash from Investing: -12
Cash from Financing: 11
: -0
Free Cash Flow: 0
OCF / Net Profit: 0.65
Cumulative 5-Year FCF: 0
OCF / Net Profit: 0.65
Cumulative 5-Year FCF: 0

Mar 2021

: -0
Cash from Investing: -3
Cash from Financing: 3
: -0
Free Cash Flow: -3
OCF / Net Profit: 0.13
Cumulative 5-Year FCF: 0
OCF / Net Profit: 0.13
Cumulative 5-Year FCF: 0

Mar 2022

: 6
Cash from Investing: -4
Cash from Financing: -3
: 0
Free Cash Flow: 6
OCF / Net Profit: 2.21
Cumulative 5-Year FCF: 0
OCF / Net Profit: 2.21
Cumulative 5-Year FCF: 0

Mar 2023

: 8
Cash from Investing: -12
Cash from Financing: 13
: 10
Free Cash Flow: -11
OCF / Net Profit: 3.56
Cumulative 5-Year FCF: 0
OCF / Net Profit: 3.56
Cumulative 5-Year FCF: 0

Mar 2024

: -16
Cash from Investing: -20
Cash from Financing: 29
: -6
Free Cash Flow: -34
OCF / Net Profit: -4.49
Cumulative 5-Year FCF: 0
OCF / Net Profit: -4.49
Cumulative 5-Year FCF: 0

Mar 2025

: -4
Cash from Investing: -14
Cash from Financing: 16
: -2
Free Cash Flow: -16
OCF / Net Profit: -0.47
Cumulative 5-Year FCF: -59
OCF / Net Profit: -0.47
Cumulative 5-Year FCF: -59

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE	-	-	-	-	-	-
EPS (₹)	0.38	-10.28	12.52	3.58	3.87	7.26
Book Value (₹)	13.29	10.84	28.79	12.41	40.96	48.19
Dividend per Share (₹)	0.00	0.00	2.00	0.00	0.00	0.10
Cash EPS (₹)	1.85	0.28	4.98	5.67	6.05	11.86
PROFITABILITY	-	-	-	-	-	-
Operating Margin %	7.31%	3.20%	8.74%	9.89%	8.01%	14.06%
Net Margin %	0.31%	-4.84%	3.94%	2.95%	3.45%	9.56%
ROE %	2.86%	-85.23%	63.16%	27.53%	12.96%	18.83%
ROCE %	4.18%	-5.71%	31.31%	21.50%	10.22%	16.40%
	0.29%	-7.27%	8.23%	4.20%	4.03%	8.17%
EFFICIENCY	-	-	-	-	-	-
Debtor Days	89	48	45	64	72	114
Inventory Days	30	27	26	45	56	72
Payable Days	194	113	107	144	124	128
	-75	-38	-36	-35	3	58
FINANCIAL HEALTH	-	-	-	-	-	-
Debt to Equity (x)	4.40x	6.87x	1.12x	2.21x	0.55x	0.82x
Interest Coverage (x)	2.07x	-1.01x	9.24x	2.92x	3.28x	5.31x
	0.71x	0.76x	0.94x	1.03x	1.39x	1.35x
GROWTH	-	-	-	-	-	-
Revenue Growth %	0.00%	70.76%	49.77%	5.92%	34.00%	-6.59%
Operating Profit Growth %	0.00%	-25.23%	309.00%	19.94%	14.83%	99.22%
Net Profit Growth %	0.00%	-2803.31%	221.70%	-20.58%	56.57%	159.14%
	0.00%	0.00%	0.00%	0.00%	8.32%	87.48%
VALUATION	-	-	-	-	-	-
P/E (x)	0.00x	0.00x	0.00x	0.00x	31.23x	16.35x
P/B (x)	0.00x	0.00x	0.00x	0.00x	2.95x	2.46x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.08%
	0.00x	0.00x	0.00x	0.00x	17.63x	9.89x

Mar 2020

EPS (₹): 0.38
Book Value (₹): 13.29
Dividend per Share (₹): 0.00
Cash EPS (₹): 1.85
Operating Margin %: 7.31%
Net Margin %: 0.31%
ROE %: 2.86%
ROCE %: 4.18%
: 0.29%
Debtor Days: 89
Inventory Days: 30
Payable Days: 194
: -75
Debt to Equity (x): 4.40x
Interest Coverage (x): 2.07x
: 0.71x
Revenue Growth %: 0.00%
Operating Profit Growth %: 0.00%
Net Profit Growth %: 0.00%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2021

EPS (₹): -10.28
Book Value (₹): 10.84
Dividend per Share (₹): 0.00
Cash EPS (₹): 0.28
Operating Margin %: 3.20%
Net Margin %: -4.84%
ROE %: -85.23%
ROCE %: -5.71%
: -7.27%
Debtor Days: 48
Inventory Days: 27
Payable Days: 113
: -38
Debt to Equity (x): 6.87x
Interest Coverage (x): -1.01x
: 0.76x
Revenue Growth %: 70.76%
Operating Profit Growth %: -25.23%
Net Profit Growth %: -2803.31%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2022

EPS (₹): 12.52
Book Value (₹): 28.79
Dividend per Share (₹): 2.00
Cash EPS (₹): 4.98
Operating Margin %: 8.74%
Net Margin %: 3.94%
ROE %: 63.16%
ROCE %: 31.31%
: 8.23%
Debtor Days: 45
Inventory Days: 26
Payable Days: 107
: -36
Debt to Equity (x): 1.12x
Interest Coverage (x): 9.24x
: 0.94x
Revenue Growth %: 49.77%
Operating Profit Growth %: 309.00%
Net Profit Growth %: 221.70%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2023

EPS (₹): 3.58
Book Value (₹): 12.41
Dividend per Share (₹): 0.00
Cash EPS (₹): 5.67
Operating Margin %: 9.89%
Net Margin %: 2.95%
ROE %: 27.53%
ROCE %: 21.50%
: 4.20%
Debtor Days: 64
Inventory Days: 45
Payable Days: 144
: -35
Debt to Equity (x): 2.21x
Interest Coverage (x): 2.92x
: 1.03x
Revenue Growth %: 5.92%
Operating Profit Growth %: 19.94%
Net Profit Growth %: -20.58%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2024

EPS (₹): 3.87
Book Value (₹): 40.96
Dividend per Share (₹): 0.00
Cash EPS (₹): 6.05
Operating Margin %: 8.01%
Net Margin %: 3.45%
ROE %: 12.96%
ROCE %: 10.22%
: 4.03%
Debtor Days: 72
Inventory Days: 56
Payable Days: 124
: 3
Debt to Equity (x): 0.55x
Interest Coverage (x): 3.28x
: 1.39x
Revenue Growth %: 34.00%
Operating Profit Growth %: 14.83%
Net Profit Growth %: 56.57%
: 8.32%
P/E (x): 31.23x
P/B (x): 2.95x
Dividend Yield %: 0.00%
: 17.63x

Mar 2025

EPS (₹): 7.26
Book Value (₹): 48.19
Dividend per Share (₹): 0.10
Cash EPS (₹): 11.86
Operating Margin %: 14.06%
Net Margin %: 9.56%
ROE %: 18.83%
ROCE %: 16.40%
: 8.17%
Debtor Days: 114
Inventory Days: 72
Payable Days: 128
: 58
Debt to Equity (x): 0.82x
Interest Coverage (x): 5.31x
: 1.35x
Revenue Growth %: -6.59%
Operating Profit Growth %: 99.22%
Net Profit Growth %: 159.14%
: 87.48%
P/E (x): 16.35x
P/B (x): 2.46x
Dividend Yield %: 0.08%
: 9.89x

Shareholding Pattern

Numbers in percentages

TRADES

	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
	72.85	72.85	72.85	72.85	72.85	72.85
	8.52	8.99	8.88	15.12	16.14	16.79
	0.00	0.00	0.00	0.68	0.00	0.00
Government	0.00	0.00	0.00	0.00	0.00	0.00
	18.64	18.16	18.27	11.35	11.01	10.36

Sep 2023

: 72.85
: 8.52
: 0.00
Government: 0.00
: 18.64

Mar 2024

: 72.85
: 8.99
: 0.00
Government: 0.00
: 18.16

Sep 2024

: 72.85
: 8.88
: 0.00
Government: 0.00
: 18.27

Mar 2025

: 72.85
: 15.12
: 0.68
Government: 0.00
: 11.35

Sep 2025

: 72.85
: 16.14
: 0.00
Government: 0.00
: 11.01

Mar 2026

: 72.85
: 16.79
: 0.00
Government: 0.00
: 10.36

Documents

Announcements

Nothing filed yet.

Annual Reports

Credit Ratings

Nothing filed yet.

Concalls

Nothing filed yet.